- Country: Germany
- Summary: Medicines with the Active Ingredient Infliximab - in the Dosage Form Powder (Atc:L04ab02)
- DET Ref No: 89376345
- Deadline: 31 Aug 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 570369-2023
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V for medicinal products with the active ingredient infliximab - in the dosage form powder for the production of an infusion solution concentrate or powder for a concentrate for the production of an infusionfusion solution (ATC: L04AB02) as part of a so-called "open-house model". All suitable and interested pharmaceutical companies or communities of pharmaceutical companies will be granted the final certificate under the stipulation of uniform contractual conditions and a uniform access procedureuss or joining a discount agreement in accordance with Section 130 a Paragraph 8 SGB V for the active ingredients mentioned under Section B. Interested pharmaceutical companies can request the participation documents and the respective contract from the contact address given under I.1). Requirement fTo conclude a contract, the interested pharmaceutical company must submit the requested participation documents, completely completed and signed.
Doc Title: Pharmaceutical products
Contract Type: Supplies - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINMedicines with the Active Ingredient Infliximab - in the Dosage Form Powder (Atc:L04ab02) - Germany Tender
The AOK SAXONY-ANHALT, a Government sector organization in Germany, has announced a new tender for Medicines with the Active Ingredient Infliximab - in the Dosage Form Powder (Atc:L04ab02). This tender is published on GermanyTenders under DET Ref No: 89376345 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-31.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
